-

08:27:34 PM

NVRO Stock News

NVRO - Nevro Corp

08/31/21 4:05 PM

NYSE : NVRO

Nevro Announces Director Appointment

Nevro Corp. (NYSE: NVRO), a global medical device company that provides innovative, evidence-based solutions for the treatment of chronic pain, today announced that Sri Kosaraju has been appointed as a member of the Board of Directors (the

RHEA-AI

very positive

08/26/21 6:00 AM

NYSE : NVRO

conferences

Nevro to Present at Baird 2021 Global Healthcare Conference

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chairman, CEO and President, will present at the

RHEA-AI

neutral

08/25/21 9:00 AM

NYSE : NVRO, RMD

Supermoon Capital Launches with World's First Fund Focused on Sleep

Supermoon Capital ( www.supermooncapital.com ), formerly SleepScore Ventures, launched today with its first venture fund of $36 million to invest in early-stage startups across all geographies working on science-backed innovations aimed to improve sleep.

RHEA-AI

neutral

08/25/21 6:00 AM

NYSE : NVRO

conferences

Nevro to Present at Morgan Stanley 19th Annual Global Healthcare Conference

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chairman, CEO and President, will present at the

RHEA-AI

neutral

08/23/21 6:00 AM

NYSE : NVRO

conferences

Nevro to Present at Wells Fargo Virtual Healthcare Conference

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chairman, CEO and President, will present at the

RHEA-AI

neutral

08/04/21 4:05 PM

NYSE : NVRO

earnings

Nevro Reports Second Quarter 2021 Financial Results and Provides Third Quarter of 2021 Guidance

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today reported its financial results for the second quarter ended June 30, 2021 and provided third

RHEA-AI

neutral

07/19/21 7:00 AM

NYSE : NVRO

fda approval

Nevro Announces FDA Approval of its 10 kHz High Frequency Spinal Cord Stimulation Therapy for Treatment of Chronic Pain Associated with Painful Diabetic Neuropathy (PDN)

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced receipt of FDA approval of its Senza® System for the treatment of chronic pain

RHEA-AI

positive

07/07/21 7:00 AM

NYSE : NVRO

conferencesearnings

Nevro to Report Second Quarter 2021 Financial Results

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the company will report its financial results for the second quarter ended June

RHEA-AI

neutral

06/22/21 6:00 AM

NYSE : NVRO

clinical trial

Nevro Announces SENZA-PDN Clinical Data Presentation at the American Diabetes Association 81st Scientific Sessions

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that data from the SENZA Painful Diabetic Neuropathy (PDN) Randomized Controlled

RHEA-AI

neutral

06/22/21 6:00 AM

NYSE : NVRO

clinical trial

Nevro Announces SENZA-NSRBP Clinical Data Presentation at the American Society of Interventional Pain Physicians 23rd Annual Meeting

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that data from the SENZA Non-Surgical Refractory Back Pain (NSRBP) Randomized

RHEA-AI

neutral

NVRO Data:

IndustrySurgical and Medical Instrument Manufacturing
Websitewww.nevro.com
CeoD.Keith Grossman
Security nameNevro Corp
Issue typecs
SectorManufacturing
Sic code3841
Employees843
Tags
- Health Technology
- Medical Specialties
- Manufacturing
- Surgical and Medical Instrument Manufacturing
Address1800 Bridge Pkwy
StateCalifornia
CityRedwood City
Zip94065-1164
CountryUS
Phone16502510005

NVRO Description:

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. HF10 therapy has demonstrated the ability to reduce or eliminate opioids in =65% of patients across six peer-reviewed clinical studies. The Senza® System, Senza II™ System, and the Senza® Omnia™ System are the only SCS systems that deliver Nevro's proprietary HF10® therapy. Senza, Senza II, Senza Omnia, HF10, Nevro and the Nevro logo are trademarks of Nevro Corp.